Newsweek features RespoKare Masks

RespoKare continues to be one of America’s leading mask brands, acclaims an article in Newsweek Amplify. The article of 1 June 2021 affirms that since 2013, RespoKare’s patented Virax technology has proven the safety protection of its masks. RespoKare masks can help kill viruses and pathogens "10,000 times more effective than an ordinary mask" - killing up to 99.99 percent of coronavirus and measles within a minute, and 99.99 percent of 15 flu virus strains in 5 minutes.

An ordinary mask captures infected droplets on its surface. It runs the risk of contaminating you when touched, while RespoKare’s mask quickly absorbs the infected droplets, traps them, and destroys them.

All masks are designed for a snug fit, and the RespoKare Anti-Viral Surgical Mask is also suitable for children ages five to 10 years.

The FDA cleared and NIOSH-approved masks stem from research and studies undertaken by its parent company, Innonix Technologies Limited. The signature masks come with four layers, with the two outer layers using their patented technology. The outermost layer is hydrophilic, which allows for the quick absorption of infected droplets into the antiviral layer (second layer). While there, the viruses are rapidly inactivated as they are exposed to high localized concentrations of copper and zinc ions, which destroy the viruses through ionic interactions with proteins and RNA or DNA.

The third and fourth layers are the filter layer for fine particles and the liquid-resistant layer for final protection, respectively.

Please read the Newsweek article here.